Rationale and Design of the Vitamin D and Type 2 Diabetes (D2d) Study: A Diabetes Prevention Trial | Zendy

Anastassios G. Pittas | Zendy; Bess DawsonHughes | Zendy; Patricia Sheehan | Zendy; Clifford J. Rosen | Zendy; James H. Ware | Zendy; William C. Knowler | Zendy; Myrlene A. Staten | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rationale and Design of the Vitamin D and Type 2 Diabetes (D2d) Study: A Diabetes Prevention Trial

Author(s) -

Anastassios G. Pittas,

Bess DawsonHughes,

Patricia Sheehan,

Clifford J. Rosen,

James H. Ware,

William C. Knowler,

Myrlene A. Staten

Publication year - 2014

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc14-1005

Subject(s) - medicine , type 2 diabetes , diabetes mellitus , prediabetes , vitamin d and neurology , research design , randomized controlled trial , glycemic , cholecalciferol , endocrinology , social science , sociology

Observational studies suggest that vitamin D may lower the risk of type 2 diabetes. However, data from long-term trials are lacking. The Vitamin D and Type 2 Diabetes (D2d) study is a randomized clinical trial designed to examine whether a causal relationship exists between vitamin D supplementation and the development of diabetes in people at high risk for type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research